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Most cases of anaplastic thyroid carcinoma can be pathologically and often historically as-
sociated with the presence of low-grade (differentiated) cancer in the thyroid. That radiation
therapy to the differentiated tumor plays an etiologic role in the transformation of a differen-
tiated to an undifferentiated tumor has been suggested. If such therapy can be implicated, is
there a difference in risk between external radiotherapy or radioactive iodine? Review of the
literature discloses that more anaplastic carcinoma ofthe thyroid develop in patients without a
history ofprior radiation than in individuals who have received radiation. We report our recent
experience with two patients who demonstrated the sequence ofwell-differentiated followed by
anaplastic thyroid cancer subsequent to radiation and review the question.
Anaplastic carcinoma of the thyroid represents one of the most aggressive of hu-
man epithelial neoplasms. A disease affecting predominantly older patients, the
average survival rate is less than two years [1,2] and long-term survival is rare. Many
of these tumors are associated pathologically with low-grade cancers in the same
gland and the relationship between the two remains unclear. Williams[3] has sug-
gested that radiation may play an etiologic role in the transformation of a well-
differentiated thyroid cancer into an anaplastic one. Alternatively, certain neo-
plasms may be composed of more than one population ofcells with variable degrees
of susceptibility to therapeutic modalities. Hence, a selection process may occur,
with less responsive cell clones surviving therapy.
We report the following two cases to refocus awareness on the problem of such a




A 66-year-old, Caucasian male presented, in September 1975, with a chief com-
plaint of aright neck mass. The mass had been noted for 13 years, with little change
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All rights of reproduction in any form reserved.in size, but with recent onset of associated pain. Physical examination revealed a
large multinodular mass occupying the right lower neck and deviating the trachea
and thyroid cartilage to the left. Needle biopsy of the neck mass showed papillary
adenocarcinoma.
On September 17, 1975, the patient underwent subtotal thyroid resection and
right radical neck dissection. The thyroid tumor consisted ofa 3 x 2 cm cystic mass
with gross extension beyond the thyroid into the soft tissue of the neck. Several
grossly involved lymph nodes were also identified.
Microscopically, the thyroid tumor was a mixed papillary and follicular carci-
noma (Fig. 1) which extended through the gland capsule and invaded muscle and
perineural spaces. Focally solid areas and squamous metaplasia were seen. Twenty-
seven cervical lymph nodes contained metastases.
The patient's postoperative course was unremarkable, and he received subsequent
radiation therapy to the neck, to a total dose of 3,960 rads.
The patient was well until October 1980 when he developed slowly progressive
neck pain and right lower extremity weakness. He was hospitalized in December
1980, at which time physical examination revealed a dense right hemiparesis and
bilateral positive Babinski reflexes. No evidence of local recurrent disease was
noted. A myelogram was performed which demonstrated extradural compression of
the right side of the upper cervical cord. The patient underwent a decompressive
laminectomy from C-2 to C-5, which revealed tumor in the subarachnoid space on
the right side apparently invading the spinal cord. The recurrent tumor in the epi-
dural space displayed a solid undifferentiated carcinoma pattern with nuclear and
cellular pleomorphism. Spindle cell areas were noted also (Fig. 2). No evidence of
differentiated papillary carcinoma was identified in these biopsy fragments. The pa-
tient was treated with an additional 3,060 rads. The patient experienced some return
of his neurological function but within one month his condition worsened, and he
expired on May 30, 1981.
Case II
A 69-year-old Caucasian male presented, in February 1967, with a two-month
history ofa rapidly developing right anterior neck mass. Examination confirmed the
presence ofa supple, irregular, firm 3.0 x 3.0 cm nodular mass anterior to the right
FIG. 1. Original mixed
papillary and follicular car-
cinoma in case 1; clear
nuclei and papillae are
shown. (H&E, x250)
522 KAPP ET AL.ETIOLOGY OF ANAPLASTIC CARCINOMA AFTER THYROID CANCER
LAr 4"i'
FIG. 2. Case 1: Epidural
^ Ct- metastasis shows undiffer-
entiated carcinoma only.
(H&E, x300)
sternocleidomastoid muscle. On February 21, 1967, a total thyroidectomy and
modified right radical neck dissection were performed. The thyroid tumor consisted
of a grossly encapsulated but microscopically infiltrating differentiated carcinoma.
It contained large zones offollicular differentiation but had clear nuclei ofpapillary
cancer and psammoma bodies (Fig. 3). Small foci of more solid tumor were seen.
One lymph node contained metastatic cancer. Thyroid scan revealed no uptake
postoperatively. The patient was placed on 3 grains ofthyroid extract per day which
he continued to take until September 1978, when three right posterior cervical
masses were noted. Excisional biopsy of one of these showed metastatic thyroid
adenocarcinoma, predominantly solid in pattern. The patient refused additional
therapy at that time and the residual cervical masses increased in size. An I-131 scan
revealed increased uptake in the right posterior cervical area, the right supraclavicu-
lar area, sternal notch, the lower left cervical area, and the thyroid cartilage. On
March 26, 1979, the patient received 140 millicuries of 1-131.
The patient was seen at Yale-New Haven Hospital on March 19, 1980, complain-
ing of pain from his right neck mass and weight loss. Physical examination at that
time disclosed 4.0 x 2.5 cm and 2.5 x 3.0 cm right posterior cervical masses which
FIG. 3. Original thyroid
cancer resected from case 2
in 1967 shows follicular pat-
tern with clear nuclei and
calcification. Occasional
; ^ t ws -::^psammoma bodies were
found. (H&E, x 100)
523KAPP ET AL.
FIG. 4. Case 2: Recurrent
neck mass in 1980 shows
giant cell tumor predomi-
nantly. Needle biopsy. - **t* w ~ * ^* v -*- (H&E, x250)
were firm and fixed. In addition, a 1.0 x 1.0 cm right supraclavicular node was ap-
preciated. Intraoral examination disclosed a large mass in the right posterior phar-
ynx. Needle biopsy showed undifferentiated carcinoma. The ultimate tumor in the
neck showed both spindle and giant cells, with marked pleomorphism and extensive
necrosis (Fig. 4). The patient's condition acutely deteriorated with diminution in vi-
sion and multiple cranial nerve palsies. The patient expired on April 9, 1980. At
autopsy multiple brain and lung metastases were noted in addition to the massive
recurrence in the neck. No differentiated carcinoma was found; the tumor in all
areas was anaplastic with predominantly giant cell pattern (Fig. 5). No evidence for
a second malignancy was identified.
DISCUSSION
These two cases represent examples of transformation of well-differentiated to
anaplastic carcinoma in the thyroid. In each case, radiation had been given to the
low-grade tumor. The possible etiological role of irradiation in this transformation
is unclear, however. Anaplastic or undifferentiated carcinoma has classically been
FIG. 5. Case 2: Cerebellar
'~(right) metastasis of giant
¶3 ~ ~ ~~~~~~~ ~cell carcinoma (left) at
Plau to~Al. autopsy. (H&E, x 100)
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divided into large cell (spindle and giant cell) and small cell types. This classification
is, however, considered doubtful, since most small cell tumors represent either
medullary thyroid cancer without amyloid or malignant lymphoma [4,5].
The large cell form is considered an epithelially derived neoplasm, usually from
follicular epithelium, and comprises about 5 percent (range, 3-10 percent) of all
thyroid malignancies [1,2,6,7]. Its exact incidence is unknown since diagnostic con-
fusion has occurred in the past with large cell malignant lymphomas (immunoblastic
sarcomas) arising in the thyroid [3,5].
Most studies of anaplastic carcinoma suggest an origin in an abnormal thyroid
[1,2,6,8]. A history of "goiter" is elicited in over 75 percent of cases [2,8]. Many of
the affected patients are elderly (over 50). Histologically, this goiter may represent
adenomatous goiter, an adenoma, or a well-differentiated carcinoma. This striking
association both by history and histology has led to the concept oftransformation of
a benign or low-grade malignant lesion to a high-grade one [1,2,6,7,8,9].
Evidence documenting this transformation sequence is impossible to obtain.
Retrospective analyses of anaplastic carcinomas have shown associated benign or
well-differentiated malignant tumors in about 80 percent of well-studied cases [7].
However, since the incidence of the highly aggressive lesions is low compared to the
well-differentiated ones, other factors need to be assessed to define the influences re-
quired for "transformation" [10]. Age may be one such factor. Since anaplastic tu-
mors occur more commonly in the elderly, there is a greater likelihood that the
harbored papillary or follicular cancer could be exposed to a transforming agent
such as virus or environmental pollutant [3]. The role of thyroid stimulating hor-
mone (TSH) must be considered, since in certain areas of the world where iodine
deficiency is prevalent anaplastic thyroid cancer is more common [3,5]; TSH might
drive the thyroid to develop well-differentiated tumors which could transform by
themselves or TSH could induce the lower grade lesions to be altered [11-15].
Radiation must be considered in thedevelopment ofanaplasticthyroid cancer [3].
The possibility that thyroid radiation might produce hypofunction in the gland and
stimulate pituitary TSH could be considered in some cases of transformation from
low- to high-grade neoplasms. Individual case reports of anaplastic thyroid cancers
following irradiation are recorded in the literature: some with external radia-
tion [7,9,16-23], some with radioiodine [10,12,23-27], others with a combination of
these [7,14,22,28-31] are rare instances following radon or radium used as the
therapeutic agent [9,13,17].
In the present report, one patient had received radioiodine and the other external
radiation to well-differentiated cancers before the transformations occurred.
The literature on this subject of radiation-associated transformation is extremely
confused in several respects. First, the type of radiation involved, its method of
delivery, and the dosages stated or calculated vary widely. Second, pathologic
categorization of the initial tumors is incomplete or poorly documented. In some
reports [9,27] reference is made to focal anaplastic areas in the original tumor, yet
their pathologic definition or illustration is lacking. Are the authors referring to
solid zones, squamous foci, or something else? Third, the patient population which
received the various modalities of irradiation differs, making a comparison of ab-
solute incidence difficult (Table 1). Finally, the pathologic classification of the
"transformed" tumor is often unclear: some are diagnosed as "sarcoma," some as
carcinoma, and others as reticulum cell sarcoma [5,20].
A review of the world's literature reveals anaplastic transformation after various
modalities of irradiation, including I-131, teletherapy, and combination of both. It
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TABLE I
Radiation Therapy Associated Transformation
of Well-Differentiated Thyroid Cancer
Type of Radiation Treatment No. of Patients References
1-131 27 [10,12,23-27]
Teletherapy 18 [7,9,16-23,32,33]
Teletherapy and I-131 8 [7,14,22,28-31]
Radium implant 1 [13]
Radon seeds 1 [9]
Radium pack 1 [17]
Teletherapy and radon seeds 1 [9]
Type unknown 3 [18]
appears that I-131 treatment has been associated more frequently [10,12,23-27] with
the transformation to higher grades ofthyroid tumor than has external beam irradi-
ation therapy [7,9,16-23,32,33] (Table 1). This may reflect the more extensive use
of 1-131 therapy in the management of well-differentiated thyroid cancers, the long
survival times in most patients managed in this manner, or a more vigorous search
for anaplastic transformation in this patient population, rather than any clear-cut
dose relationship for induction of transformation. More often, however, anaplastic
TABLE 2
Anaplastic Transformation in Well-Differentiated Thyroid Cancer
Anaplastic Transformation:
No. of Pts. History of
Authors Reference Patient Population Prior Irradiation
YES NO
Tollefsen et al. [34] Patients with spindle cell and/or 8 10
giant cell carcinoma in addition to
papillary Ca.
Wychulis et al. [22] Patients with mixed papillary and 3 13
anaplastic carcinoma out of 162
patients with anaplastic cancers
Pochin [27] Patients (192) with mainly differ- 8a -
entiated and inoperable thyroid
cancers treated with 1-131
Nishiyama et al. [7] Patients with anaplastic carcinoma 2b 39
found in conjunction with well-
differentiated thyroid cancers out of
53 patients with anaplastic Ca.
Harada et al. [18] Patients with "accelerated growth 4 10
pattem" of anaplastic thyroid cancer
Aldinger et al. [26] Patients with anaplastic carcinomas lOc 8
who had a prior history of differen-
tiated thyroid cancer out of 84
patients with spindle and giant cell
cancers of the thyroid
aThree had biopsies showing partially anaplastic carcinomas prior to 1-131 treatment.
'A third patient developed anaplastic thyroid cancer three years after I-131 treatment for thyrotoxicosis.
cAll had I-131 treatment.
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tumors develop in patients who have not received any irradiation treatments for
their well-differentiated thyroid carcinoma [34] (Table 2).
However, although most anaplastic tumors are derived in association with or
from pre-existing differentiated cancers, only a small number of the latter progress.
Indeed, the proportion is so small that the possibility of anaplastic transformation
should not determine the treatment of low-grade cancer. Winship and Rosvoll re-
ported three anaplastic transformations in 331 patients with papillary and follicular
cancer following extensive beam irradiation [19]. Recently, no cases of transforma-
tion were reported in 352 patients treated at M.D. Anderson with I-131 for well-
differentiated thyroid cancers [35]. Similarly, no cases of anaplastic transformation
were mentioned by Tubiana in 359 patients with thyroid cancer treated with external
radiation therapy or radioiodine [36].
If radiotherapy appears indicated for control of unresectable or locally recurrent
differentiated thyroid tumors, it should be given. The rare event of transformation,
an almost uniformly lethal circumstance, should not interfere with needed ther-
apy [3,10].
Since dedifferentiation of low-grade thyroid cancers is considered a major mode of
development of anaplastic carcinomas [37], it could be argued that our two patients
represent cases of the natural history of transformation of papillary carcinomas;
i.e., that the radiation was incidental. We recognize that the latency period in our
Case 2 was relatively short for radiation induction of tumor; however, it is unclear
what temporal relationships are acceptable for radiation-associated transformation
of an already established malignant neoplasm. Careful attention to all possible etio-
logical factors in the transformation of well-differentiated thyroid cancers into
anaplastic carcinomas in future studies will be necessary to help define the role of
radiation therapy in this process.
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